These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11941224)

  • 1. Combined Use of Thyroid Hormone and ECT.
    Stern RA; Steketee MC; Durr AL; Prange AJ; Golden RN
    Convuls Ther; 1993; 9(4):285-292. PubMed ID: 11941224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thyroid hormone to diminish the cognitive side effects of psychiatric treatment.
    Tremont G; Stern RA
    Psychopharmacol Bull; 1997; 33(2):273-80. PubMed ID: 9230642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
    Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A
    Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dissociation between anterograde and retrograde amnesia after treatment with electroconvulsive therapy: a naturalistic investigation.
    O'Connor M; Lebowitz BK; Ly J; Panizzon MS; Elkin-Frankston S; Dey S; Bloomingdale K; Thall M; Pearlman C
    J ECT; 2008 Jun; 24(2):146-51. PubMed ID: 18580560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing the cognitive effects of lithium therapy and electroconvulsive therapy using thyroid hormone.
    Tremont G; Stern RA
    Int J Neuropsychopharmacol; 2000 Jun; 3(2):175-186. PubMed ID: 11343594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study.
    Matthews JD; Blais M; Park L; Welch C; Baity M; Murakami J; Sklarsky K; Homberger C; Fava M
    J Psychiatr Res; 2008 Jun; 42(7):526-31. PubMed ID: 17681545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Working memory disturbances in patients with major depression after ECT treatment].
    Datka W; Siwek M; Dudek D; Maczka G; Zieba A
    Psychiatr Pol; 2007; 41(3):339-49. PubMed ID: 17900050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical examination of bifrontal electroconvulsive therapy: clinical efficacy, cognitive side effects, and directions for future research.
    Crowley K; Pickle J; Dale R; Fattal O
    J ECT; 2008 Dec; 24(4):268-71. PubMed ID: 18648318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The practice of electroconvulsive therapy in Malawi.
    Selis MA; Kauye F; Leentjens AF
    J ECT; 2008 Jun; 24(2):137-40. PubMed ID: 18580558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis.
    Bolwig TG; Madsen TM
    Acta Psychiatr Scand Suppl; 2007; (433):130-5. PubMed ID: 17280579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive shock alters the rat overt rhythms of motor activity and temperature without altering the circadian pacemaker.
    Anglès-Pujolràs M; Díez-Noguera A; Soria V; Urretavizcaya M; Menchón JM; Cambras T
    Behav Brain Res; 2009 Jan; 196(1):37-43. PubMed ID: 18706453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective controlled study into memory complaints reported by depressed patients after treatment with electroconvulsive therapy and pharmacotherapy or pharmacotherapy only.
    Kho KH; VanVreeswijk MF; Murre JM
    J ECT; 2006 Sep; 22(3):199-205. PubMed ID: 16957537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of Iba1-expressing microglial process density in the hippocampus following electroconvulsive shock.
    Jinno S; Kosaka T
    Exp Neurol; 2008 Aug; 212(2):440-7. PubMed ID: 18538764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of electroconvulsive therapy in the elderly: a study from the psychiatric unit of a north Indian teaching hospital.
    Jain G; Kumar V; Chakrabarti S; Grover S
    J ECT; 2008 Jun; 24(2):122-7. PubMed ID: 18580554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on the Mechanism of Action of Electroconvulsive Therapy: Anticonvulsant, Peptidergic, c-fos Proto-oncogene Effects.
    Nakajima T; Post RM; Pert A; Ketter TA; Weiss SR
    Convuls Ther; 1989; 5(3):274-295. PubMed ID: 11941026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation.
    Mikkelsen JD; Woldbye DP
    J Psychiatr Res; 2006 Mar; 40(2):153-9. PubMed ID: 16459171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory performance in severely depressed patients treated by electroconvulsive therapy.
    Hihn H; Baune BT; Michael N; Markowitsch H; Arolt V; Pfleiderer B
    J ECT; 2006 Sep; 22(3):189-95. PubMed ID: 16957535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.